The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Charge variants in IgG1: Isolation, characterization, in vitro binding properties and pharmacokinetics in rats
Open accessAbstract
Antibody charge variants have gained considerable attention in the biotechnology industry due to their potential influence on stability and biological activity. Subtle differences in the relative proportions of charge variants are often observed during routine biomanufacture or process changes and pose a challenge to demonstrating product comparability. To gain further insights into the impact on biological activity and pharmacokinetics (PK) of monoclonal antibody (mAb) charge heterogeneity, we isolated the major charge forms of a recombinant humanized IgG1 and compared their in vitro properties and in vivo PK. The mAb starting material had a pI range of 8.7-9.1 and was composed of about 20% acidic variants, 12% basic variants, and 68% main peak. Cation exchange displacement chromatography was used to isolate the acidic, basic, and main peak fractions for animal studies. Detailed analyses were performed on the isolated fractions to identify specific chemical modification contributing to the charge differences, and were also characterized for purity and in vitro potency prior to being administered either subcutaneously (SC) or intravenously (IV) in rats. All isolated materials had similar potency and rat FcRn binding relative to the starting material. Following IV or SC administration (10 mg/kg) in rats, no difference in serum PK was observed, indicating that physiochemical modifications and pI differences among charge variants were not sufficient to result in PK changes. Thus, these results provided meaningful information for the comparative evaluation of charge-related heterogeneity of mAbs, and suggested that charge variants of IgGs do not affect the in vitro potency, FcRn binding affinity, or the PK properties in rats.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
FcRn: the neonatal Fc receptor comes of age
Roopenian, D. C., & Akilesh, S. (2007) · Nature Reviews Immunology · doi:10.1038/nri2155 · Cited by 2,346
Charge density-dependent strength of hydration and biological structure
Collins, K. D. (1997) · Biophysical Journal · doi:10.1016/s0006-3495(97)78647-8 · Cited by 1,334
Shields, R. L., Namenuk, A. K., Hong, K., Meng, Y. G., Rae, J., Briggs, J., Xie, D., Lai, J., Stadlen, A., Li, B., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009483200 · Cited by 1,161
Antibody Structure, Instability, and Formulation
Wang, W., Singh, S., Zeng, D. L., King, K., & Nema, S. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20727 · Cited by 941
Improving the efficacy of antibody-based cancer therapies
Carter, P. (2001) · Nature Reviews Cancer · doi:10.1038/35101072 · Cited by 833
Microlymphatics and lymph flow
Schmid-Schonbein, G. W. (1990) · Physiological Reviews · doi:10.1152/physrev.1990.70.4.987 · Cited by 613
Ober, R. J., Radu, C. G., Ghetie, V., & Ward, E. S. (2001) · International Immunology · doi:10.1093/intimm/13.12.1551 · Cited by 501
Identification of multiple sources of charge heterogeneity in a recombinant antibody
Harris, R. J., Kabakoff, B., Macchi, F. D., Shen, F. J., Kwong, M., Andya, J. D., Shire, S. J., Bjork, N., Totpal, K., & Chen, A. B. (2001) · Journal of Chromatography B: Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)00548-x · Cited by 500
Self-citationBoswell, C. A., Sun, X., Niu, W., Weisman, G. R., Wong, E. H., Rheingold, A. L., & Anderson, C. J. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030383m · Cited by 483
Characterizing biological products and assessing comparability following manufacturing changes
Chirino, A. J., & Mire-Sluis, A. (2004) · Nature Biotechnology · doi:10.1038/nbt1030 · Cited by 364
Pressure effects on intra- and intermolecular interactions within proteins
Boonyaratanakornkit, B. B., Park, C. B., & Clark, D. S. (2002) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(01)00347-8 · Cited by 352
Petkova, S. B., Akilesh, S., Sproule, T. J., Christianson, G. J., Al Khabbaz, H., Brown, A. C., Presta, L. G., Meng, Y. G., & Roopenian, D. C. (2006) · International Immunology · doi:10.1093/intimm/dxl110 · Cited by 314
Pharmacokinetic aspects of biotechnology products
Tang, L., Persky, A. M., Hochhaus, G., & Meibohm, B. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20125 · Cited by 303
Structural and Functional Characterization of Disulfide Isoforms of the Human IgG2 Subclass
Dillon, T. M., Ricci, M. S., Vezina, C., Flynn, G. C., Liu, Y. D., Rehder, D. S., Plant, M., Henkle, B., Li, Y., Deechongkit, S., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709988200 · Cited by 291
Human IgG2 Antibodies Display Disulfide-mediated Structural Isoforms
Wypych, J., Li, M., Guo, A., Zhang, Z., Martinez, T., Allen, M. J., Fodor, S., Kelner, D. N., Flynn, G. C., Liu, Y. D., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709987200 · Cited by 286
Eaton, D. L., Wood, W. I., Eaton, D., Hass, P. E., Hollingshead, P., Wion, K., Mather, J., Lawn, R. M., Vehar, G. A., & Gorman, C. (1986) · Biochemistry · doi:10.1021/bi00374a001 · Cited by 267
In Vivo Deamidation Characterization of Monoclonal Antibody by LC/MS/MS
Huang, L., Lu, J., Wroblewski, V. J., Beals, J. M., & Riggin, R. M. (2005) · Analytical Chemistry · doi:10.1021/ac0494174 · Cited by 266
Reduced elimination of IgG antibodies by engineering the variable region
Igawa, T., Tsunoda, H., Tachibana, T., Maeda, A., Mimoto, F., Moriyama, C., Nanami, M., Sekimori, Y., Nabuchi, Y., Aso, Y., et al. (2010) · Protein Engineering Design and Selection · doi:10.1093/protein/gzq009 · Cited by 265 · cited 3×
“Evidence has been presented that deliberately modifying the pI of an antibody by approximately one pI unit or more can give noticeable differences in the pharmacokinetics (PK) of an intact mAb.(29,30) Most studies of antibody charge modifications have involved intravenous (IV) administration; in contrast, there is lit…”
BackgroundHeterogeneity of Monoclonal Antibodies Revealed by Charge-Sensitive Methods
Vlasak, J., & Ionescu, R. (2008) · Current Pharmaceutical Biotechnology · doi:10.2174/138920108786786402 · Cited by 260
Subcutaneous drug delivery and the role of the lymphatics
McLennan, D. N., Porter, C. J. H., & Charman, S. A. (2005) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2005.05.006 · Cited by 259
Site-specific covalent modification of monoclonal antibodies: in vitro and in vivo evaluations.
Rodwell, J. D., Alvarez, V. L., Lee, C., Lopes, A. D., Goers, J. W., King, H. D., Powsner, H. J., & McKearn, T. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.8.2632 · Cited by 246
Development of radioimmunotherapeutic and diagnostic antibodies: an inside-out view
Boswell, C. A., & Brechbiel, M. W. (2007) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2007.04.001 · Cited by 241
Yeung, Y. A., Leabman, M. K., Marvin, J. S., Qiu, J., Adams, C. W., Lien, S., Starovasnik, M. A., & Lowman, H. B. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804182 · Cited by 237
Methionine oxidation in human IgG2 Fc decreases binding affinities to protein A and FcRn
Pan, H., Chen, K., Chu, L., Kinderman, F., Apostol, I., & Huang, G. (2009) · Protein Science · doi:10.1002/pro.45 · Cited by 203
Harris, R. J., Shire, S. J., & Winter, C. (2004) · Drug Development Research · doi:10.1002/ddr.10344 · Cited by 198
Self-citationChumsae, C., Gaza-Bulseco, G., Sun, J., & Liu, H. (2007) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.11.050 · Cited by 191
Andya, J. D., Maa, Y.-F., Costantino, H. R., Nguyen, P.-A., Dasovich, N., Sweeney, T. D., Hsu, C. C., & Shire, S. J. (1999) · Pharmaceutical Research · doi:10.1023/a:1018805232453 · Cited by 190
Wright, A., & Morrison, S. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3393 · Cited by 158
Lyubarskaya, Y. V., Houde, D. J., Woodard, J. P., Murphy, D., & Mhatre, R. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2005.10.003 · Cited by 147
Determination of the Origin of Charge Heterogeneity in a Murine Monoclonal Antibody
Perkins, M. D., Theiler, R., Lunte, S. M., & Jeschke, M. (2000) · Pharmaceutical Research · doi:10.1023/a:1026461830617 · Cited by 140
Wang, E., Brown, P. S., Aroeti, B., Chapin, S. J., Mostov, K. E., & Dunn, K. W. (2000) · Traffic · doi:10.1034/j.1600-0854.2000.010606.x · Cited by 140
Surface Charge: A Key Determinant of Protein Localization and Function
Goldenberg, N. M., & Steinberg, B. E. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2905 · Cited by 140
Jones, A. J. S., Papac, D. I., Chin, E. H., Keck, R. G., Baughman, S. A., Lin, Y. S., Kneer, J., & Battersby, J. E. (2007) · Glycobiology · doi:10.1093/glycob/cwm017 · Cited by 137
Cation exchange–HPLC and mass spectrometry reveal C-terminal amidation of an IgG1 heavy chain
Johnson, K. A., Paisley-Flango, K., Tangarone, B. S., Porter, T. J., & Rouse, J. C. (2006) · Analytical Biochemistry · doi:10.1016/j.ab.2006.10.012 · Cited by 127
Zheng, J. Y., & Janis, L. J. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.024 · Cited by 124
Putnam, W. S., Prabhu, S., Zheng, Y., Subramanyam, M., & Wang, Y. (2010) · Trends in biotechnology · doi:10.1016/j.tibtech.2010.07.001 · Cited by 103
Accessibility of circulating immunoglobulin G to the extravascular compartment of solid rat tumors.
O'Connor, S. W., & Bale, W. F. (1984) · PubMed · Cited by 99
Martin, W. L., & Björkman, P. J. (1999) · Biochemistry · doi:10.1021/bi9913505 · Cited by 90
Antes, B., Amon, S., Rizzi, A. M., Wiederkum, S., Kainer, M., Szolar, O. H. J., Fido, M., Kircheis, R., & Nechansky, A. (2007) · Journal of Chromatography B · doi:10.1016/j.jchromb.2007.01.024 · Cited by 86
Biomedical Aspects of Drug Targeting
(2002) · Springer eBooks · doi:10.1007/978-1-4757-4627-3 · Cited by 80
Lee, H., & Pardridge, W. M. (2003) · Bioconjugate Chemistry · doi:10.1021/bc0256648 · Cited by 78
Perera, R. M., Zoncu, R., Johns, T. G., Pypaert, M., Lee, F.-T., Mellman, I., Old, L. J., Toomre, D. K., & Scott, A. M. (2007) · Neoplasia · doi:10.1593/neo.07721 · Cited by 75
Flexibility—the guiding principle for antibody manufacturing
Carson, K. L. (2005) · Nature Biotechnology · doi:10.1038/nbt0905-1054 · Cited by 71
Developmental regulation of sialic acid modifications in rat and human colon
Muchmore, E. A., Varki, N. M., Fukuda, M., & Varki, A. P. (1987) · The FASEB Journal · doi:10.1096/fasebj.1.3.3623000 · Cited by 59
Hong, G., Bazin-Redureau, M., & Scherrmann, J. M. G. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js970335n · Cited by 44
Khawli, L. A., Mizokami, M. M., Sharifi, J., Hu, P., & Epstein, A. L. (2002) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/108497802760363150 · Cited by 44
Self-citationX-ray crystallographic studies of IgG-Fcγ receptor interactions
Sondermann, P., & Oosthuizen, V. (2002) · Biochemical Society Transactions · doi:10.1042/bst0300481 · Cited by 35
Improved Tumor Localization and Radioimaging with Chemically Modified Monoclonal Antibodies
Khawli, L. A., Glasky, M. S., Alauddin, M. M., & Epstein, A. L. (1996) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.1996.11.203 · Cited by 27
Self-citationImproving monoclonal antibody pharmacokinetics via chemical modification.
Sharifi, J., Khawli, L. A., Hornick, J. L., & Epstein, A. L. (1998) · PubMed · Cited by 25
Self-citationFactors affecting pharmacokinetics of monoclonal antibodies: A review article.
Iznaga-Escobar, N., Mishra, A., & Pérez-Rodríguez, R. (2004) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.2004.26.2.800065 · Cited by 21
Modification of antibody isoelectric point affects biodistribution of 111-indium-labeled antibody
Gangopadhyay, A., Petrick, A. T., & Thomas, P. (1996) · Nuclear Medicine and Biology · doi:10.1016/0969-8051(95)02057-8 · Cited by 20
Effect of isoelectric point on biodistribution and inflammation imaging with indium-111-labelled IgG
KATE, C. I. T., Fischman, A. J., Rubin, R. H., Fucello, A. J., Riexinger, D., Wilkinson, R. A., Du, L., Khaw, B., & Strausś, H. W. (1990) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf01268020 · Cited by 20
Pardridge, W. M., Kang, Y. S., Diagne, A., & Zack, J. A. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12257-x · Cited by 17
Full-length antibodies on display
Sidhu, S. S. (2007) · Nature Biotechnology · doi:10.1038/nbt0507-537 · Cited by 15
Bickel, U., Lee, V. M. ‐., & Pardridge, W. M. (1995) · Drug Delivery · doi:10.3109/10717549509031361 · Cited by 15
Boswell, C. A., Deng, R., Lin, K., et al. (2009) · CRC Press eBooks · doi:10.3109/9781420078077-5 · Cited by 8
Cited by
Pharmacokinetics of Monoclonal Antibodies
Ryman, J. T., & Meibohm, B. (2017) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12224 · Cited by 802
Characterization of Therapeutic Antibodies and Related Products
Beck, A., Wagner-Rousset, E., Ayoub, D., Van Dorsselaer, A., & Sanglier-Cianférani, S. (2013) · Analytical Chemistry · doi:10.1021/ac3032355 · Cited by 587
Physicochemical Stability of Monoclonal Antibodies: A Review
Le Basle, Y., Chennell, P., Tokhadze, N., Astier, A., & Sautou, V. (2020) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2019.08.009 · Cited by 429
Effects of Charge on Antibody Tissue Distribution and Pharmacokinetics
Boswell, C. A., Tesar, D. B., Mukhyala, K., Theil, F.-P., Fielder, P. J., & Khawli, L. A. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100261d · Cited by 398
Self-citationPharmacokinetics of monoclonal antibodies and Fc-fusion proteins
Liu, L. (2018) · Protein & Cell · doi:10.1007/s13238-017-0408-4 · Cited by 390
Metadata
- Authors
- Khawli, L. A., Goswami, S., Hutchinson, R., Kwong, Z. W., Yang, J., Wang, X., Yao, Z., Sreedhara, A., Cano, T., Tesar, D. B., Nijem, I., Allison, D. E., Wong, P. Y., Kao, Y.-H., Quan, C., Joshi, A., Harris, R. J., & Motchnik, P.
- Venue
- mAbs
- Publisher
- Informa UK Limited
- Published
- 2010-11
- Volume
- 2
- Issue
- 6
- Pages
- 613-624
- ISSN
- 1942-0862 (ISSN-L)
- 1942-0870
- OpenAlex
- W1483007604
- Cited by
- 419
- References
- 56
- FWCI
- 4.14
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.